CMA imposes substantial fines on pharma firms for overcharging the NHS
16th July 2021 Uncategorised 0Competition regulator announces fines totalling £260m relating to the supply of hydrocortisone tablets
More: CMA imposes substantial fines on pharma firms for overcharging the NHS
Source: News